Neonatal risks of maternal treatment with mood stabilizers.
Olfson
Mark
M
Marcus
Steven
S
D000927:Anticonvulsants / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D018020:Lithium Compounds / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D012107:Research Design / Q000592:standards*; D012127:Respiratory Distress Syndrome, Newborn / Q000139:chemically induced*; D012307:Risk Factors; D015983:Selection Bias; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012720:Severity of Illness Index
D000927:Anticonvulsants; D018020:Lithium Compounds; D017367:Selective Serotonin Reuptake Inhibitors